NeuroOne Medical Technologies Corporation (NMTC)

NASDAQ: NMTC · IEX Real-Time Price · USD
1.84
-0.05 (-2.65%)
At close: Aug 12, 2022 4:00 PM
1.81
-0.03 (-1.63%)
After-hours: Aug 12, 2022 7:37 PM EDT
-2.65%
Market Cap 29.80M
Revenue (ttm) 162,065
Net Income (ttm) -11.27M
Shares Out 16.19M
EPS (ttm) -0.83
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 155,583
Open 1.85
Previous Close 1.89
Day's Range 1.65 - 1.94
52-Week Range 0.51 - 6.80
Beta 0.95
Analysts Buy
Price Target 2.68 (+45.7%)
Earnings Date Aug 11, 2022

About NMTC

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with R... [Read more...]

Industry Health Care Equipment & Supplies
Founded 2009
Employees 11
Stock Exchange NASDAQ
Ticker Symbol NMTC
Full Company Profile

Financial Performance

In 2021, NMTC's revenue was $242,958, a decrease of -87.39% compared to the previous year's $1.93 million. Losses were -$9.95 million, -27.07% less than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for NMTC stock is "Buy." The 12-month stock price forecast is 2.68, which is an increase of 45.65% from the latest price.

Price Target
$2.68
(45.65% upside)
Analyst Consensus: Buy
Stock Forecasts

News

NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn. , Aug. 11, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical car...

NeuroOne® Submits Special 510(k) to FDA for Evo® sEEG Electrode

Company re-submits application to gain FDA clearance for less than 30 day use EDEN PRAIRIE, Minn. , Aug. 9, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or t...

NeuroOne® to Report Third Quarter Fiscal Year 2022 Financial Results on August 11

EDEN PRAIRIE, Minn. , Aug. 4, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care...

NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode

Amendment provides Zimmer Biomet with 350,000 warrants with exercise price of $3.00 per share EDEN PRAIRIE, Minn. , Aug. 3, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ...

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode

Case performed at Emory University for intraoperative brain mapping EDEN PRAIRIE, Minn. , July 12, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Compa...

NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders

Letter recaps key highlights of fiscal year 2021 and features upcoming milestones for fiscal year 2022 and beyond EDEN PRAIRIE, Minn. , June 2, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corpora...

NeuroOne® to Present Its Breakthrough Technology for Monitoring Neural Activity at the H.C. Wainwright Global Investm...

EDEN PRAIRIE, Minn. , May 19, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ:  NMTC ) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ca...

NeuroOne Provides Evo® sEEG Update

The Evo®  sEEG electrode 510(k) cleared for temporary (less than 24 hours) use remains in effect and the Company will explore the opportunity to market the device for intraoperative use. EDEN PRAIRIE, M...

NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn. , May 12, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care...

NeuroOne® to Report Second Quarter Fiscal Year 2022 Financial Results on May 12

EDEN PRAIRIE, Minn. , May 3, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...

NeuroOne® to Present its Disruptive Next-Generation Diagnostic Electrode Technology at the NobleCon18 Investor Confer...

EDEN PRAIRIE, Minn. , April 18, 2022  /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical c...

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

EDEN PRAIRIE, Minn. , April 5, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical car...

NeuroOne® Investor Call Replay Available Through April 11th

EDEN PRAIRIE, Minn. , March 30, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ca...

NeuroOne® to Host Investor Call About Recent Disclosures Tomorrow March 29th at 10:00 am ET

EDEN PRAIRIE, Minn. , March 28, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ca...

NeuroOne Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EDEN PRAIRIE, Minn., March 4, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care...

NeuroOne to Present its Game-Changing Neuroscientific Technology at the Oppenheimer 32nd Annual Healthcare Conference...

EDEN PRAIRIE, Minn., March 3, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care...

NeuroOne® Releases Successful Completion of Long-Term Stimulation Tests for its Novel Thin Film Platform Electrode Te...

EDEN PRAIRIE, Minn., March 2, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care...

NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Feb. 14, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care...

NeuroOne® Medical Technologies Corporation Releases Successful Long-Term Recording Test Data for its Novel Thin Film ...

EDEN PRAIRIE, Minn., Feb. 8, 2022  /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care...

NeuroOne to Host First Quarter Fiscal Year 2022 Earnings Call

EDEN PRAIRIE, Minn., Feb. 2, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...

NeuroOne Appoints Chad Wilhelmy, as Vice President of Quality Control and Regulatory Affairs

EDEN PRAIRIE, Minn., Jan. 18, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care...

NeuroOne Featured on The Medical Alley Podcast: "A Conversation with Dave Rosa, President and CEO, NeuroOne"

EDEN PRAIRIE, Minn., Dec. 20, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care...

NeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Dec. 15, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...

NeuroOne to Host Fourth Quarter 2021 Earnings Call

EDEN PRAIRIE, Minn., Dec. 6, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...

NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock

EDEN PRAIRIE, Minn., Oct. 13, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the "Company"), a medical technology company focused on improving surgical care options and o...